Hem › Post-COVID-tillstånd (Long COVID) › District of Columbia
Kliniska studier för Post-COVID-tillstånd (Long COVID) i District of Columbia
4 studier för Post-COVID-tillstånd (Long COVID) söker deltagare vid platser i District of Columbia.
Städer i District of Columbia
Officiell studietext (engelska)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Georgetown University Medical Center, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Georgetown University Medical Center, Washington D.C.
- Emerson Clinical Research Institute, Washington D.C.
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06679140T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
- Children's National Hospital, Washington D.C.
RekryterarFas 1
Ålder 2 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT05141058Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.